Isabella De Angelis

Dr. Isabella De Angelis


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Cells
Verified
Journal Article
Open access
PDF file
OVOlimpia Vincentini
Olimpia Vincentini
VPValentina Prota
Valentina Prota
SCSerena Cecchetti
Serena Cecchetti
LBLUCIA BERTUCCINI
LUCIA BERTUCCINI
ATAntonella Tinari
Antonella Tinari
IAIsabella De Angelis
Isabella De Angelis
Increasing interest is being addressed to the development of a reliable, reproducible and relevant in vitro model of intestinal barrier, mainly for engineered nanomaterials hazard and risk assessment, in order to meet regulatory and scientific demands. Starting from the consolidated Caco-2 cell model, widely used for determining translocation of drugs and chemicals, the establishment of an advanced intestinal barrier model with different level of complexity is important for overcoming Caco-2 monoculture limitations. For this purpose, a tri-culture model, consisting of two human intestinal epithelial cells (Caco-2 and HT29-MTX) and a human lymphocyte B cell (Raji B), was developed by several research groups to mimic the in vivo intestinal epithelium, furnishing appropriate tools for nanotoxicological studies. However, tri-culture model shows high levels of variability in ENM uptake/translocation studies. With the aim of implementing the standardization and optimization of this tri-culture for ENM translocation studies, the present paper intends to identify and discuss such relevant parameters involved in model establishment as: tri-culture condition set-up, barrier integrity evaluation, mucus characterization, M-cell induction. SiO2 fluorescent nanoparticles were used to compare the different models. Although a low level of SiO2 translocation is reported for all the different culture conditions. a relevant role of mucus and M-cells in NPs uptake/translocation has been highlighted.

17 June 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
CCCatherine Carnovale
Catherine Carnovale
DGDaniela Guarnieri
Daniela Guarnieri
LCLuisana Di Cristo
Luisana Di Cristo
IAIsabella De Angelis
Isabella De Angelis
GVGiulia Veronesi
Giulia Veronesi
SSStefania Sabella
Stefania Sabella
Grouping approaches of nanomaterials have the potential to facilitate high throughput and cost effective nanomaterial screening. However, an effective grouping of nanomaterials hinges on the application of suitable physicochemical descriptors to identify similarities. To address the problem, we developed an integrated testing approach coupling acellular and cellular phases, to study the full life cycle of ingested silver nanoparticles (NPs) and silver salts in the oro-gastrointestinal (OGI) tract including their impact on cellular uptake and integrity. This approach enables the derivation of exposure-dependent physical descriptors (EDPDs) upon biotransformation of undigested nanoparticles, digested nanoparticles and digested silver salts. These descriptors are identified in: size, crystallinity, chemistry of the core material, dissolution, high and low molecular weight Ag-biomolecule soluble complexes, and are compared in terms of similarities in a grouping hypothesis. Experimental results indicate that digested silver nanoparticles are neither similar to pristine nanoparticles nor completely similar to digested silver salts, due to the presence of different chemical nanoforms (silver and silver chloride nanocrystals), which were characterized in terms of their interactions with the digestive matrices. Interestingly, the cellular responses observed in the cellular phase of the integrated assay (uptake and inflammation) are also similar for the digested samples, clearly indicating a possible role of the soluble fraction of silver complexes. This study highlights the importance of quantifying exposure-related physical descriptors to advance grouping of NPs based on structural similarities.

11 February 2025 in Nanomaterials
Verified
Journal Article
Open access
PDF file
BBBeatrice Battistini
Beatrice Battistini
DLDaniela Lulli
Daniela Lulli
BBBeatrice Bocca
Beatrice Bocca
MCMaria Luigia Carbone
Maria Luigia Carbone
CRCarmela Ramondino
Carmela Ramondino
CFCristina M Failla
Cristina M Failla
Tattoo inks contain varying amounts of metal nanoparticles (NPs) < 100 nm that, due to their unique physicochemical properties, may have specific biological uptake and cause skin or systemic toxicities. The toxic effects of certified reference standards of metal NPs and samples of commercially available tattoo inks were investigated using an in vitro system and a novel human ex vivo model. In vitro toxicity was evaluated using vitality assays on human skin cells (HaCaT cell line, primary fibroblasts, and keratinocytes). No toxicity was observed for Al2O3, Cr2O3, Fe2O3, and TiO2 NPs, whereas CuO NPs showed dose-dependent toxicity on HaCaT and primary fibroblasts. Fibroblasts and keratinocytes were also sensitive to high concentrations of ZnO NPs. Reference standards and ink samples were then injected ex vivo into human skin explants using tattoo needles. Histological analysis showed pigment distribution deep in the dermis and close to dermal vessels, suggesting possible systemic diffusion. The presence of an inflammatory infiltrate was also observed. Immunohistochemical analysis showed increased apoptosis and expression of the inflammatory cytokine interleukin-8 in explants specifically tattooed with the reference standard or red ink. Taken together, the results suggest that the tattooing technique leads to exposure to toxic metal NPs and skin damage.